These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24080384)

  • 1. Pre-clinical cognitive phenotypes for Alzheimer disease: a latent profile approach.
    Hayden KM; Kuchibhatla M; Romero HR; Plassman BL; Burke JR; Browndyke JN; Welsh-Bohmer KA
    Am J Geriatr Psychiatry; 2014 Nov; 22(11):1364-74. PubMed ID: 24080384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single neuropsychological test scores associated with rate of cognitive decline in early Alzheimer disease.
    Parikh M; Hynan LS; Weiner MF; Lacritz L; Ringe W; Cullum CM
    Clin Neuropsychol; 2014; 28(6):926-40. PubMed ID: 25131004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring cognitive change in subjects with prodromal Alzheimer's disease.
    Mura T; Proust-Lima C; Jacqmin-Gadda H; Akbaraly TN; Touchon J; Dubois B; Berr C
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):363-70. PubMed ID: 23840054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Cognitive Decline Prior to Dementia in Persons with Mild Cognitive Impairment.
    Cloutier S; Chertkow H; Kergoat MJ; Gauthier S; Belleville S
    J Alzheimers Dis; 2015; 47(4):901-13. PubMed ID: 26401770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    Williams OA; An Y; Armstrong NM; Kitner-Triolo M; Ferrucci L; Resnick SM
    J Alzheimers Dis; 2020; 75(4):1169-1180. PubMed ID: 32390623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure of the National Alzheimer's Coordinating Centers uniform dataset neuropsychological battery: an evaluation of invariance between and within groups over time.
    Hayden KM; Jones RN; Zimmer C; Plassman BL; Browndyke JN; Pieper C; Warren LH; Welsh-Bohmer KA
    Alzheimer Dis Assoc Disord; 2011; 25(2):128-37. PubMed ID: 21606904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical AD predicts decline in memory and executive functions in subjective complaints.
    van Harten AC; Smits LL; Teunissen CE; Visser PJ; Koene T; Blankenstein MA; Scheltens P; van der Flier WM
    Neurology; 2013 Oct; 81(16):1409-16. PubMed ID: 24049134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Latent Transition Analysis Model to Assess Change in Cognitive States over Three Occasions: Results from the Rush Memory and Aging Project.
    Zammit AR; Bennett DA; Hall CB; Lipton RB; Katz MJ; Muniz-Terrera G
    J Alzheimers Dis; 2020; 73(3):1063-1073. PubMed ID: 31884467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive phenotypes in Parkinson's disease: A latent profile analysis.
    Barvas E; Mattavelli G; Zappini F; Giardina F; Ottaviani D; Papagno C
    Neuropsychology; 2021 May; 35(4):451-459. PubMed ID: 34043394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Decline in Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease: A Prospective Cohort Study.
    Hamilton CA; Matthews FE; Donaghy PC; Taylor JP; O'Brien JT; Barnett N; Olsen K; Lloyd J; Petrides G; McKeith IG; Thomas AJ
    Am J Geriatr Psychiatry; 2021 Mar; 29(3):272-284. PubMed ID: 32863138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographically Corrected Normative Z Scores on the Neuropsychological Test Battery in Cognitively Normal Older Chinese Adults.
    Ruan Q; Xiao F; Gong K; Zhang W; Zhang M; Ruan J; Zhang X; Chen Q; Yu Z
    Dement Geriatr Cogn Disord; 2020; 49(4):375-383. PubMed ID: 33176318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological networks in cognitively healthy older adults and dementia patients.
    Nevado A; Del Rio D; Pacios J; Maestú F
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2022 Sep; 29(5):903-927. PubMed ID: 34415217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor analyses of the ADNI neuropsychological battery: An examination of diagnostic and longitudinal invariance.
    Chang M; Brainerd CJ
    Neuropsychology; 2021 May; 35(4):434-450. PubMed ID: 34043393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal Cognitive Profiles in Diabetes: Results From the National Alzheimer's Coordinating Center's Uniform Data.
    Sano M; Zhu CW; Grossman H; Schimming C
    J Am Geriatr Soc; 2017 Oct; 65(10):2198-2204. PubMed ID: 28771679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline.
    Donohue MC; Sperling RA; Salmon DP; Rentz DM; Raman R; Thomas RG; Weiner M; Aisen PS; ; ;
    JAMA Neurol; 2014 Aug; 71(8):961-70. PubMed ID: 24886908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective cognitive concerns and neuropsychiatric predictors of progression to the early clinical stages of Alzheimer disease.
    Donovan NJ; Amariglio RE; Zoller AS; Rudel RK; Gomez-Isla T; Blacker D; Hyman BT; Locascio JJ; Johnson KA; Sperling RA; Marshall GA; Rentz DM
    Am J Geriatr Psychiatry; 2014 Dec; 22(12):1642-51. PubMed ID: 24698445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.